Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Deloitte
Merck
Express Scripts
Farmers Insurance
Fuji
QuintilesIMS
Fish and Richardson
Chubb

Generated: July 17, 2018

DrugPatentWatch Database Preview

Midodrine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for midodrine hydrochloride and what is the scope of midodrine hydrochloride patent protection?

Midodrine hydrochloride
is the generic ingredient in three branded drugs marketed by Apotex Inc, Casi Pharms Inc, Impax Pharms, Mylan Pharms Inc, Upsher-smith Labs, and Shire Llc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for midodrine hydrochloride. Sixteen suppliers are listed for this compound.
Pharmacology for midodrine hydrochloride
Medical Subject Heading (MeSH) Categories for midodrine hydrochloride
Synonyms for midodrine hydrochloride
( -)-Midodrin hydrochloride
( -)-Midodrine hydrochloride
(+-)-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride
(+-)-Midodrin hydrochloride
(+-)-Midodrine hydrochloride
[+/-]-1-[2,5-Dimethoxyphenyl]-2-glycinamidoethanol
092M179
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
2- degrees +/->>u-N-[2-(2,5- paragraph signthorn(1/4)xNo>>u+/-(1/2)>>u)-2-oCOO>>u]OOo pound degrees .
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide monohydrochloride
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-acetamide hydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride
2-Amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide monohydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide, chloride
2-azanyl-N-[2-(2,5-dimethoxyphenyl)-2-oxidanyl-ethyl]ethanamide hydrochloride
218M560
3092-17-9
43218-56-0
A 4020 Linz
A-4020 Linz
A820652
AC1L2BU9
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride, (+-)-
Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride
Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, monohydrochloride, (+-)-
ACM43218560
AKOS015895724
Alphamine
Amatine
API0001437
API0024416
C12H18N2O4.HCl
C12H19ClN2O4
CAS-3092-17-9
CCG-39323
CHEBI:31847
CHEMBL1200461
CPD000058833
CS-4689
CTK1D6108
D01307
DSSTox_CID_27493
DSSTox_GSID_47493
DSSTox_RID_82380
DTXSID1047493
EINECS 256-148-3
FT-0603627
FT-0701302
Gutron
Hipertan
HMS1568H03
HMS1922O03
HS-0099
HY-12749A
I06-0865
LS-8042
LS-8052
MCULE-8615039451
Metligene
MGCQZNBCJBRZDT-UHFFFAOYSA-N
Midamine
Midodrine (hydrochloride)
Midodrine HCL
Midodrine hydrochloride (JAN/USAN)
Midodrine hydrochloride [USAN:JAN]
Midodrine hydrochloride [USAN:USP:JAN]
Midodrine hydrochloride [USAN]
Midodrine hydrochloride, analytical standard, for drug analysis
Midodrine hydrochloride, United States Pharmacopeia (USP) Reference Standard
MLS001332567
MLS001332568
MLS002154233
MolPort-003-666-473
NC00573
NCGC00016620-01
NCGC00095311-01
NCGC00178238-05
NCGC00256810-01
NSC-758429
NSC758429
Pharmakon1600-01503257
Prestwick_625
Pro-Amatine
Pro-Amatine (TN)
ProAmatine
Q-201404
rac-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide hydrochloride
s120
SAM002564219
SBB066174
SCHEMBL41463
SMR000058833
SPECTRUM1503257
St 1085 [as the base]
ST-1085 [As The Base]
St. Peter 224
ST51037351
TL8002369
Tox21_110529
Tox21_110529_1
Tox21_302723
TS 701
VA11298

US Patents and Regulatory Information for midodrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 077746-002 Sep 12, 2006 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 076577-002 Sep 10, 2003 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shire Llc PROAMATINE midodrine hydrochloride TABLET;ORAL 019815-003 Mar 20, 2002 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Pharms MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 076449-001 May 27, 2004 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Fuji
Daiichi Sankyo
Federal Trade Commission
Cipla
Mallinckrodt
Cantor Fitzgerald
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.